As of 2025-07-14, the Relative Valuation of Arcturus Therapeutics Holdings Inc (ARCT) is (34.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.78 USD, the upside of Arcturus Therapeutics Holdings Inc based on Relative Valuation is -353.7%.
The range of the Relative Valuation is (21.63) - (47.48) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 18.9x | 13.6x |
| Forward P/E multiples | 8.6x - 21.5x | 14.2x |
| Fair Price | (21.63) - (47.48) | (34.96) |
| Upside | -256.9% - -444.5% | -353.7% |
| Date | P/E |
| 2025-07-10 | -5.76 |
| 2025-07-09 | -5.88 |
| 2025-07-08 | -5.49 |
| 2025-07-07 | -5.31 |
| 2025-07-03 | -5.48 |
| 2025-07-02 | -5.42 |
| 2025-07-01 | -5.17 |
| 2025-06-30 | -5.17 |
| 2025-06-27 | -5.30 |
| 2025-06-26 | -5.73 |
| 2025-06-25 | -5.55 |
| 2025-06-24 | -5.33 |
| 2025-06-23 | -4.97 |
| 2025-06-20 | -4.89 |
| 2025-06-18 | -4.91 |
| 2025-06-17 | -4.88 |
| 2025-06-16 | -5.12 |
| 2025-06-13 | -4.92 |
| 2025-06-12 | -5.03 |
| 2025-06-11 | -4.95 |
| 2025-06-10 | -5.13 |
| 2025-06-09 | -4.99 |
| 2025-06-06 | -5.09 |
| 2025-06-05 | -4.74 |
| 2025-06-04 | -4.88 |
| 2025-06-03 | -5.17 |
| 2025-06-02 | -5.09 |
| 2025-05-30 | -4.98 |
| 2025-05-29 | -5.06 |
| 2025-05-28 | -4.70 |
| 2025-05-27 | -4.78 |
| 2025-05-23 | -4.85 |
| 2025-05-22 | -5.09 |
| 2025-05-21 | -4.83 |
| 2025-05-20 | -5.05 |
| 2025-05-19 | -4.77 |
| 2025-05-16 | -4.63 |
| 2025-05-15 | -4.63 |
| 2025-05-14 | -4.31 |
| 2025-05-13 | -4.72 |
| 2025-05-12 | -4.61 |
| 2025-05-09 | -4.37 |
| 2025-05-08 | -4.53 |
| 2025-05-07 | -4.35 |
| 2025-05-06 | -4.47 |
| 2025-05-05 | -4.74 |
| 2025-05-02 | -5.10 |
| 2025-05-01 | -4.97 |
| 2025-04-30 | -5.09 |
| 2025-04-29 | -5.10 |